SVB Wealth’s Abeona Therapeutics ABEO Stock Holding History

SVB Wealth’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-780	Closed	-$4K	–	989
2022 Q2	$4K	Hold	780	–	–	﹤0.01%	755
2022 Q1	$6K	Hold	780	–	–	﹤0.01%	780
2021 Q4	$7K	Hold	780	–	–	﹤0.01%	792
2021 Q3	$22K	Hold	780	–	–	﹤0.01%	976
2021 Q2	$30K	Hold	780	–	–	﹤0.01%	952
2021 Q1	$37K	Buy	+780	New	+$43K	﹤0.01%	888

Other funds holding ABEO

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SVB Wealth's ABEO Position: Q3 2022 in Review

SVB Wealth sold out of Abeona Therapeutics (ABEO) in Q3 2022, closing a stake of 780 shares — an estimated $4K sold.

SVB Wealth first reported a position in ABEO in Q1 2021 and held it in 6 quarters. The position peaked at $37K in Q1 2021. 24 funds tracked by Wall St. Rank hold ABEO as of Q3 2022.

SVB Wealth reported no remaining Abeona Therapeutics position as of Q3 2022 after selling out during the quarter.
SVB Wealth sold 780 Abeona Therapeutics shares in Q3 2022, an estimated $4K.
SVB Wealth first reported a position in Abeona Therapeutics in Q1 2021 and held it in 6 quarters.
SVB Wealth's Abeona Therapeutics position peaked at $37K in Q1 2021.
24 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2022.

Based on SVB Wealth's 13F filing for Q3 2022, filed 9 Nov 2022.